TEYI PHARMACEUTICAL GROUP CO (SZSE:002728) ROCE % : 2.45% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is TEYI PHARMACEUTICAL GROUP CO ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TEYI PHARMACEUTICAL GROUP CO's annualized ROCE % for the quarter that ended in Mar. 2024 was 2.45%.

TEYI PHARMACEUTICAL GROUP CO ROCE % Historical Data

The historical data trend for TEYI PHARMACEUTICAL GROUP CO's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TEYI PHARMACEUTICAL GROUP CO ROCE % Chart

TEYI PHARMACEUTICAL GROUP CO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

16.12

6.71

11.98

15.00

17.76

TEYI PHARMACEUTICAL GROUP CO Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															35.20	15.43	11.30	15.94	2.45

TEYI PHARMACEUTICAL GROUP CO ROCE % Calculation

TEYI PHARMACEUTICAL GROUP CO's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	309.359	/	( ( (2545.605 - 1109.246)	+	(2512.637 - 465.765) )	/ 2 )
	=	309.359	/	( (1436.359	+	2046.872)	/ 2 )
	=	309.359	/	1741.6155
	=	17.76 %

TEYI PHARMACEUTICAL GROUP CO's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	50.324	/	( ( (2512.637 - 465.765)	+	(2469.349 - 413.579) )	/ 2 )
	=	50.324	/	( ( 2046.872	+	2055.77 )	/ 2 )
	=	50.324	/	2051.321
	=	2.45 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

TEYI PHARMACEUTICAL GROUP CO (SZSE:002728) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

TEYI PHARMACEUTICAL GROUP CO ROCE % Related Terms

Thank you for viewing the detailed overview of TEYI PHARMACEUTICAL GROUP CO's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

TEYI PHARMACEUTICAL GROUP CO (SZSE:002728) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TEYI PHARMACEUTICAL GROUP CO LTD (SZSE:002728) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Industrial Park pit, Guangdong Province, North, Taishan, CHN

Website

http://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO LTD is a pharmaceutical company. It engages in the research and development, production, and sale of proprietary Chinese medicines, and chemical drugs and raw materials in China. The main pharmaceutical preparation products cover a cough and phlegm, kidney, anti-infection, cardiovascular and digestive system. The main preparation products include Zhikebao Tablet, Jinqi Shenqi Tablet, Pharyngitis Tablet, and Erythromycin Enteric-coated Tablets.

Executives

Zhang Yong Zhao	Executives
Chen Xi Liang	Directors, Directors, and Executives
Xu Shao Hua	Securities Affairs Representative
Xu Wei Gao	Director
Xu Song Qing	Directors, executives
Liu Guang Tao	Executives
Du Yong Chun	Supervisors
Huang Yan Ling	Executives
Chen Guang Ting	Supervisors

TEYI PHARMACEUTICAL GROUP CO (SZSE:002728) Headlines

No Headlines